Shane Clarke

956 total citations
17 papers, 714 citations indexed

About

Shane Clarke is a scholar working on Rheumatology, Surgery and Biomedical Engineering. According to data from OpenAlex, Shane Clarke has authored 17 papers receiving a total of 714 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Rheumatology, 6 papers in Surgery and 4 papers in Biomedical Engineering. Recurrent topics in Shane Clarke's work include Osteoarthritis Treatment and Mechanisms (8 papers), Rheumatoid Arthritis Research and Therapies (7 papers) and Lower Extremity Biomechanics and Pathologies (4 papers). Shane Clarke is often cited by papers focused on Osteoarthritis Treatment and Mechanisms (8 papers), Rheumatoid Arthritis Research and Therapies (7 papers) and Lower Extremity Biomechanics and Pathologies (4 papers). Shane Clarke collaborates with scholars based in United Kingdom and United States. Shane Clarke's co-authors include John Kirwan, John C. Duddy, Raquel Granell, P. T. Dawes, M F Shadforth, P D Fowler, Mohammed Sharif, B Szebenyi, Paul Dieppe and Brian Quilty and has published in prestigious journals such as Annals of the Rheumatic Diseases, Osteoporosis International and Osteoarthritis and Cartilage.

In The Last Decade

Shane Clarke

17 papers receiving 672 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shane Clarke United Kingdom 9 587 235 146 101 96 17 714
Aida Aydemir United States 12 466 0.8× 169 0.7× 61 0.4× 146 1.4× 65 0.7× 26 756
J. Neidel Germany 13 393 0.7× 195 0.8× 29 0.2× 54 0.5× 58 0.6× 26 751
O. Niggemeyer Germany 12 383 0.7× 316 1.3× 99 0.7× 112 1.1× 192 2.0× 27 787
W. Yu China 10 396 0.7× 362 1.5× 173 1.2× 35 0.3× 289 3.0× 15 768
Tadamasa Hanyu Japan 16 284 0.5× 291 1.2× 36 0.2× 45 0.4× 130 1.4× 44 774
Shu Kobayashi Japan 17 137 0.2× 384 1.6× 94 0.6× 29 0.3× 108 1.1× 60 691
Kai-Yuan Cheng China 11 279 0.5× 109 0.5× 26 0.2× 41 0.4× 51 0.5× 25 547
Wolfram Neumann Germany 19 213 0.4× 589 2.5× 79 0.5× 33 0.3× 219 2.3× 27 917
Elisa Assirelli Italy 14 207 0.4× 163 0.7× 19 0.1× 56 0.6× 98 1.0× 35 543
Shunji Nakano Japan 16 161 0.3× 258 1.1× 27 0.2× 64 0.6× 25 0.3× 39 674

Countries citing papers authored by Shane Clarke

Since Specialization
Citations

This map shows the geographic impact of Shane Clarke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shane Clarke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shane Clarke more than expected).

Fields of papers citing papers by Shane Clarke

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shane Clarke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shane Clarke. The network helps show where Shane Clarke may publish in the future.

Co-authorship network of co-authors of Shane Clarke

This figure shows the co-authorship network connecting the top 25 collaborators of Shane Clarke. A scholar is included among the top collaborators of Shane Clarke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shane Clarke. Shane Clarke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Marciniak, Stefan J., Shane Clarke, Venkatesh Lakshminarayanan, et al.. (2025). POS0597 SAFETY, TOLERABILITY, AND ACTIVITY OF JNJ-67484703 IN PARTICIPANTS WITH ACTIVE RHEUMATOID ARTHRITIS: RESULTS OF A MULTICENTER, DOUBLE-BLIND, PLACEBO-CONTROLLED, RANDOMIZED, MULTIPLE-DOSE PHASE 1b STUDY. Annals of the Rheumatic Diseases. 84. 794–795. 1 indexed citations
2.
Orlando, Giorgio, et al.. (2024). Longitudinal assessment of physical function in adults with X-linked hypophosphatemia following initiation of burosumab therapy. Osteoporosis International. 35(11). 2055–2060. 1 indexed citations
3.
Dieppe, Paul, et al.. (2008). 471 QUANTITATIVE SENSORY TESTING IN OSTEOARTHRITIS OF THE KNEE. Osteoarthritis and Cartilage. 16. S204–S204. 6 indexed citations
4.
McAllister, Catherine, et al.. (2006). Juvenile idiopathic arthritis: Joint destruction vs joint repair. Clinical and histological findings in early untreated disease.. Research Portal (Queen's University Belfast). 54. 1 indexed citations
5.
Szebenyi, B, Anthony P. Hollander, Paul Dieppe, et al.. (2005). Associations between pain, function, and radiographic features in osteoarthritis of the knee. Bristol Research (University of Bristol). 54(1). 230–235. 172 indexed citations
6.
Sharif, Mohammed, Raquel Granell, Julia S. Johansen, et al.. (2005). Serum cartilage oligomeric matrix protein and other biomarker profiles in tibiofemoral and patellofemoral osteoarthritis of the knee. Lara D. Veeken. 45(5). 522–526. 39 indexed citations
7.
Clarke, Shane, et al.. (2004). Intra-articular hylan G-F 20 (Synvisc®) in the management of patellofemoral osteoarthritis of the knee (POAK). The Knee. 12(1). 57–62. 51 indexed citations
8.
Clarke, Shane, C.J. Wakeley, John C. Duddy, et al.. (2004). Dual-energy X-ray absorptiometry applied to the assessment of tibial subchondral bone mineral density in osteoarthritis of the knee. Skeletal Radiology. 33(10). 588–95. 43 indexed citations
10.
Sharif, Mohammed, John Kirwan, Christopher J. Elson, Raquel Granell, & Shane Clarke. (2004). Suggestion of nonlinear or phasic progression of knee osteoarthritis based on measurements of serum cartilage oligomeric matrix protein levels over five years. Arthritis & Rheumatism. 50(8). 2479–2488. 118 indexed citations
11.
Sharif, Mohammed, et al.. (2003). A 5 year longitudinal study of serum cartilage oligomeric martix protein in patients with tibiofemoral osteoarthritis of the knee. Bristol Research (University of Bristol). 2 indexed citations
12.
Plant, Michael, Andrew Hassell, M F Shadforth, et al.. (1997). Management of oral complications of disease-modifying drugs in rheumatoid arthritis. Lara D. Veeken. 36(4). 473–478. 8 indexed citations
13.
Hassell, Andrew, Michael Plant, Shane Clarke, et al.. (1995). SMALL JOINT SYNOVTTIS IN RHEUMATOID ARTHRITIS: SHOULD IT BE ASSESSED SEPARATELY?. Lara D. Veeken. 34(1). 51–55. 7 indexed citations
14.
Hassell, Andrew, Martin J. Davis, P D Fowler, et al.. (1993). The relationship between serial measures of disease activity and outcome in rheumatoid arthritis. QJM. 86(9). 601–7. 55 indexed citations
15.
Scott, David L., P. T. Dawes, E J Tunn, et al.. (1989). COMBINATION THERAPY WITH GOLD AND HYDROXYCHLOROQUINE IN RHEUMATOID ARTHRITIS: A PROSPECTIVE, RANDOMIZED, PLACEBO-CONTROLLED STUDY. Lara D. Veeken. 28(2). 128–133. 62 indexed citations
17.
Clarke, Shane, et al.. (1984). Post-traumatic small bowel stenosis.. PubMed. 29(4). 256–7. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026